GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abivax SA (LTS:0RA9) » Definitions » 5-Year Yield-on-Cost %

Abivax (LTS:0RA9) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Abivax 5-Year Yield-on-Cost %?

Abivax's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Abivax's 5-Year Yield-on-Cost % or its related term are showing as below:



LTS:0RA9's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.735
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Abivax's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Abivax's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abivax's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abivax's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Abivax's 5-Year Yield-on-Cost % falls into.



Abivax 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Abivax is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Abivax  (LTS:0RA9) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Abivax 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Abivax's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abivax Business Description

Address
7-11 boulevard Haussmann, Paris, FRA, 75009
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Abivax Headlines

No Headlines